These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26385136)

  • 21. [Vaccination against bluetongue serotype 8 in the Netherlands].
    Kuijk H; Jansen M; Moulin V; Makoschey B
    Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439
    [No Abstract]   [Full Text] [Related]  

  • 22. The bluetongue outbreak in North-West Europe: the outcome from the epidemiological investigation coordinated by the European Food Safety Authorities (EFSA).
    Rodeia SP; Deluyker H; Pfeiffer DU; Salman MD
    Prev Vet Med; 2008 Oct; 87(1-2):1-3. PubMed ID: 18635277
    [No Abstract]   [Full Text] [Related]  

  • 23. New introduction of bluetongue 'very likely'.
    Loeb J
    Vet Rec; 2024 May; 194(10):370. PubMed ID: 38757855
    [No Abstract]   [Full Text] [Related]  

  • 24. Bluetongue: virological and epidemiological observations in Israel.
    Barzilai E; Shimshony A
    Prog Clin Biol Res; 1985; 178():545-53. PubMed ID: 2989902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology of bluetongue virus serotype 8 outbreaks in the Netherlands in 2006].
    Elbers A; Backx A; van der Spek A; Ekker M; Leijs P; Steijn K; van Langen H; van Rijn P
    Tijdschr Diergeneeskd; 2008 Mar; 133(6):222-9. PubMed ID: 18429403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands.
    Elbers AR; Backx A; Meroc E; Gerbier G; Staubach C; Hendrickx G; van der Spek A; Mintiens K
    Prev Vet Med; 2008 Oct; 87(1-2):21-30. PubMed ID: 18620767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of bluetongue in an epizootic situation: Australian plans.
    Geering WA
    Aust Vet J; 1975 Apr; 51(4):220-32. PubMed ID: 169798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of human interventions on the spread of bluetongue virus serotype 8 during the 2006 epidemic in north-western Europe.
    Mintiens K; Méroc E; Faes C; Abrahantes JC; Hendrickx G; Staubach C; Gerbier G; Elbers AR; Aerts M; De Clercq K
    Prev Vet Med; 2008 Oct; 87(1-2):145-61. PubMed ID: 18649960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bluetongue control strategy.
    Bardsley M
    Vet Rec; 2008 Sep; 163(13):398-9. PubMed ID: 18820331
    [No Abstract]   [Full Text] [Related]  

  • 30. Expected utility of voluntary vaccination in the middle of an emergent Bluetongue virus serotype 8 epidemic: a decision analysis parameterized for Dutch circumstances.
    Sok J; Hogeveen H; Elbers AR; Velthuis AG; Oude Lansink AG
    Prev Vet Med; 2014 Aug; 115(3-4):75-87. PubMed ID: 24768508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of an early warning system against bluetongue virus in Switzerland.
    Racloz V; Straver R; Kuhn M; Thur B; Vanzetti T; Stärk KD; Griot C; Cagienard A
    Schweiz Arch Tierheilkd; 2006 Nov; 148(11):593-8. PubMed ID: 17209508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bluetongue in Denmark during 2008.
    Rasmussen LD; Rasmussen TB; Belsham GJ; Strandbygaard B; Bøtner A
    Vet Rec; 2010 Jun; 166(23):714-8. PubMed ID: 20525947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian optimisation of restriction zones for bluetongue control.
    Spooner T; Jones AE; Fearnley J; Savani R; Turner J; Baylis M
    Sci Rep; 2020 Sep; 10(1):15139. PubMed ID: 32934252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bluetongue is a bigger problem than most people think].
    Vrouenraets R
    Tijdschr Diergeneeskd; 2006 Oct; 131(20):746-7. PubMed ID: 17073384
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vaccination against bluetongue: safety and immune response in the field].
    Bruckner L; Fricker R; Hug M; Hotz R; Muntwyler J; Iten C; Griot C
    Schweiz Arch Tierheilkd; 2009 Mar; 151(3):101-8. PubMed ID: 19263379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal vaccination strategies against vector-borne diseases.
    Græsbøll K; Enøe C; Bødker R; Christiansen LE
    Spat Spatiotemporal Epidemiol; 2014 Oct; 11():153-62. PubMed ID: 25457604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiologic characteristics of bluetongue virus serotype 8 laboratory-confirmed outbreaks in The Netherlands in 2007 and a comparison with the situation in 2006.
    Elbers AR; van der Spek AN; van Rijn PA
    Prev Vet Med; 2009 Nov; 92(1-2):1-8. PubMed ID: 19740560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What BTV-8 can do, any other serotype can do, too].
    Haneveld JK
    Tijdschr Diergeneeskd; 2008 Oct; 133(20):856-8. PubMed ID: 18975627
    [No Abstract]   [Full Text] [Related]  

  • 39. ["An European problem in the making". Report on information evening about bluetongue].
    Westerbeek J
    Tijdschr Diergeneeskd; 2006 Sep; 131(18):667-8. PubMed ID: 17017601
    [No Abstract]   [Full Text] [Related]  

  • 40. Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands.
    Elbers AR; Backx A; Mintiens K; Gerbier G; Staubach C; Hendrickx G; van der Spek A
    Prev Vet Med; 2008 Oct; 87(1-2):31-40. PubMed ID: 18620768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.